Diabetes Care Devices - Israel

  • Israel
  • Revenue in the Diabetes Care Devices market market in Israel is anticipated to reach US$106.30m in 2024.
  • This revenue is expected to exhibit an annual growth rate (CAGR 2024-2029) of 12.42%, leading to a market volume of US$190.90m by 2029.
  • In a global context, the majority of revenue will be generated the United States, with projections of US$11,710.00m in 2024.
  • Israel's innovative landscape in diabetes care devices is driving significant advancements in technology, enhancing patient outcomes and fostering a vibrant startup ecosystem.

Key regions: Netherlands, Japan, France, Italy, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Diabetes Care Devices Market in Israel is experiencing considerable growth, fueled by advancements in technology, increasing prevalence of diabetes, and heightened awareness of disease management among patients, enhancing accessibility and treatment options.

Customer preferences:
Consumers in Israel are increasingly prioritizing personalized diabetes management solutions, reflecting a growing preference for tailored health care experiences. This trend is driven by a tech-savvy population that values user-friendly diabetes care devices, such as smart glucose monitors and insulin pumps with connectivity features. Additionally, the rising awareness of preventive health measures and lifestyle modifications has led to a demand for integrated apps that provide real-time data and support, promoting proactive disease management and enhancing patient engagement.

Trends in the market:
In Israel, the Diabetes Care Devices Market is experiencing a surge in demand for advanced glucose monitoring systems, including continuous glucose monitors (CGMs) and smart insulin delivery systems. This trend reflects a shift towards more integrated diabetes management solutions that enhance patient autonomy and enable real-time data sharing with healthcare providers. The increasing prevalence of diabetes, coupled with a rising emphasis on preventive care, is driving the development of apps that support lifestyle adjustments and medication adherence. For industry stakeholders, these trends signify a need for investment in innovative technologies and partnerships that enhance user experience and engagement, ultimately improving patient outcomes.

Local special circumstances:
In Israel, the Diabetes Care Devices Market is uniquely influenced by a strong technological ecosystem and a high level of health awareness among the population. The country's advanced research and development capabilities foster innovation in diabetes management technologies, particularly in smart devices and apps designed for real-time monitoring. Additionally, cultural attitudes towards preventive health and lifestyle management encourage widespread adoption of these devices. Regulatory support for digital health solutions further accelerates market growth, positioning Israel as a leader in diabetes care innovation.

Underlying macroeconomic factors:
The Diabetes Care Devices Market in Israel is significantly shaped by macroeconomic factors such as national economic stability, healthcare investment, and global market trends. Israel’s robust economy, characterized by high GDP per capita and strong tech sector growth, fosters innovation in medical technology. Government fiscal policies that prioritize healthcare funding and support for research and development further enhance the environment for diabetes care solutions. Additionally, global trends towards preventive healthcare and personalized medicine are driving local demand for advanced diabetes management devices, ensuring continuous market expansion and adoption of innovative technologies.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)